Trillium Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics

TRIL 20.36

+2.0%

Nov 26 2:56 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bladerunner17 who wrote (138)	1/4/2018 6:51:54 PM
From: ghmm	of 294

I actually added a bit today too. I tend to hold long term and just wanted to build a little bigger position. As for now I thought they're actually in better shape than a year ago (cash and progress). I was disappointed they don't have more combination cohorts but I guess when your a tiny company you don't want to be paying for a lot of expensive drugs. Even if they're not ready to do a deal (from their end or enough data to attract a partner), I hoped they could do a Nektar like collaboration with someone where each supplies drug that could open up more combination cohorts. Nektar had a very liberal 2 year tie up to do so with BMY (which ends later this year).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next